• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Mid-Afternoon Market Update: Dow Tumbles 500 Points; Bluerock Residential Growth Shares Spike Higher

    12/20/21 2:49:19 PM ET
    $BHIL
    $BRG
    $CANF
    $CCL
    Packaged Foods
    Consumer Staples
    Real Estate Investment Trusts
    Real Estate
    Get the next $BHIL alert in real time by email

    Toward the end of trading Monday, the Dow traded down 1.42% to 34,862.49 while the NASDAQ fell 1.38% to 14,960.51. The S&P also fell, dropping 1.34% to 4,558.87.

    The U.S. has the highest number of coronavirus cases and deaths in the world, reporting a total of 51,765,710 cases with around 827,320 deaths. India confirmed a total of at least 34,746,830 cases and 477,550 deaths, while Brazil reported over 22,213,760 COVID-19 cases with 617,830 deaths. In total, there were at least 275,075,790 cases of COVID-19 worldwide with more than 5,372,280 deaths.


    Leading and Lagging Sectors


    Consumer staples shares fell by just 0.5% on Monday. Meanwhile, top gainers in the sector included Local Bounti Corporation (NYSE:LOCL), up 10% and Benson Hill, Inc. (NYSE:BHIL) up 7%.


    In trading on Monday, financials shares tumbled 2.7%.


    Top Headline


    Carnival Corp (NYSE:CCL) reported weaker-than-expected revenue for its fourth quarter.

    The cruise operator's quarterly revenue rose to $1.29 billion from $34 million in the year-ago period. However, analysts were expecting revenue of $1.41 billion. Carnival posted quarterly adjusted net loss of $2 billion.


    Equities Trading UP


    Society Pass Incorporated (NASDAQ:SOPA) shares shot up 232% to $11.00 after the company was added to the Russell 2000.


    Shares of Bluerock Residential Growth REIT, Inc. (NYSE:BRG) got a boost, shooting 71% to $26.45. Blackstone agreed to buy Bluerock Residential Growth REIT in a deal valued at $3.6 billion, extending its push into U.S. rental housing.


    Can-Fite BioPharma Ltd. (NYSE:CANF) shares were also up, gaining 64% to $2.0850 after the company announced a liver cancer patient was cleared of all cancer lesions.


    Check out these big movers of the day


    Equities Trading DOWN

    Summit Therapeutics Inc. (NASDAQ:SMMT) shares tumbled 49% to $2.55 after reporting topline results for Phase III Ri-CoDIFy study for C. Difficile infection. The company said Ri-CoDIFy did not meet primary endpoint.


    Shares of Spruce Biosciences, Inc. (NASDAQ:SPRB) were down 26% to $3.7450. Spruce Biosciences shares jumped more than 102% on Friday after Oppenheimer initiated coverage on the stock with an Outperform rating and a $15 price target.


    Optical Cable Corporation (NASDAQ:OCC) was down, falling 25% to $4.86 after the company reported Q4 earnings results.


    Commodities

    In commodity news, oil traded down 5.1% to $67.22, while gold traded down 0.6% to $1,793.80.


    Silver traded down 1% Monday to $22.315 while copper rose 0.1% to $4.2985.


    Euro zone

    European shares closed lower today. The eurozone’s STOXX 600 declined 1.38%, the Spanish Ibex Index fell 0.83% and the German DAX 30 dipped 1.88%. Meanwhile, the London’s FTSE 100 dropped 0.99%, French CAC 40 fell 0.82% and Italy’s FTSE MIB dipped 1.63%.

    The Eurozone current account surplus shrank to EUR 20.5 billion in October from EUR 31 billion in the year-ago period. The goods surplus, meanwhile, narrowed to EUR 17.8 billion from EUR 39 billion.


    Economics


    The index of leading economic indicators rose 1.1% for November, versus analysts’ expectations for a 0.8% growth.


    Check out the full economic calendar here

    Get the next $BHIL alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $BHIL
    $BRG
    $CANF
    $CCL

    CompanyDatePrice TargetRatingAnalyst
    Carnival Corporation
    $CCL
    3/19/2026$31.00Equal-Weight → Overweight
    Morgan Stanley
    Summit Therapeutics Inc.
    $SMMT
    3/16/2026$15.00Buy → Hold
    Jefferies
    Spruce Biosciences Inc.
    $SPRB
    12/23/2025$283.00Outperform
    Oppenheimer
    Summit Therapeutics Inc.
    $SMMT
    12/17/2025$18.00Underweight → Equal Weight
    Barclays
    Spruce Biosciences Inc.
    $SPRB
    12/3/2025$160.00Market Perform → Outperform
    Leerink Partners
    Summit Therapeutics Inc.
    $SMMT
    11/18/2025Peer Perform
    Wolfe Research
    Carnival Corporation
    $CCL
    11/18/2025$37.00Overweight
    Wells Fargo
    Spruce Biosciences Inc.
    $SPRB
    10/28/2025$254.00Mkt Perform → Mkt Outperform
    Citizens JMP
    More analyst ratings

    $BHIL
    $BRG
    $CANF
    $CCL
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Xia Yu bought $9,999,983 worth of shares (533,617 units at $18.74) (SEC Form 4)

    4 - Summit Therapeutics Inc. (0001599298) (Issuer)

    10/23/25 9:06:30 PM ET
    $SMMT
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Co-Chief Executive Officer Duggan Robert W bought $499,983 worth of shares (26,680 units at $18.74) and was granted 14,247,597 shares, increasing direct ownership by 3% to 570,073,879 units (SEC Form 4)

    4 - Summit Therapeutics Inc. (0001599298) (Issuer)

    10/23/25 4:08:30 PM ET
    $SMMT
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Co-Chief Executive Officer Zanganeh Mahkam was granted 14,247,597 shares and bought $499,983 worth of shares (26,680 units at $18.74) (SEC Form 4)

    4 - Summit Therapeutics Inc. (0001599298) (Issuer)

    10/23/25 4:06:32 PM ET
    $SMMT
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $BHIL
    $BRG
    $CANF
    $CCL
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    CARNIVAL CORPORATION & PLC ACHIEVES RECORD FIRST QUARTER OPERATING RESULTS AND RECORD BOOKINGS

    Introduces PROPEL, ambitious targets designed to reflect continued earnings growth momentum through 2029Announces initial $2.5 billion share buyback programMIAMI, March 27, 2026 /PRNewswire/ -- Carnival Corporation & plc ((NYSE/LSE: CCL, NYSE:CUK) announced financial results for the first quarter 2026 and provided an updated outlook. Diluted EPS of $0.19 and adjusted EPS1 of $0.20, up 50 percent compared to the prior year.Record revenues2 of $6.2 billion, gross margin yields up nearly 10 percent and record net yields1,2 (in constant currency), outperforming guidance on strong close-in demand.Bookings for 2026 up double digits, further strengthening the company's record booked position at his

    3/27/26 9:15:00 AM ET
    $CCL
    $CUK
    Marine Transportation
    Consumer Discretionary

    Multiple Ivonescimab Data Sets from Phase III Studies in Advanced NSCLC Patient Populations to be Featured at ELCC 2026

    Three Poster Presentations Will Feature Updated Ivonescimab Data, including Intracranial Anti-Tumor Activity from the Global HARMONi Phase III Study Summit Therapeutics Inc. (NASDAQ:SMMT) ("Summit," "we," or the "Company") today announced that data for its novel, potential first-in-class investigational bispecific antibody, ivonescimab, will be presented at the 2026 European Lung Cancer Congress (ELCC 2026) in Copenhagen, Denmark. Three posters featuring updated ivonescimab data will be displayed on Friday, March 27 from 1:00 to 2:00 pm Central European Time. Data for HARMONi was generated and analyzed by Summit and for HARMONi-2 by our collaboration and licensing partner, Akeso Inc. (HKE

    3/27/26 8:15:00 AM ET
    $SMMT
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Holland America Line and Jefferson's Bourbon Make History with the First Bourbon Aged on Cruise Ships

    For the first time, bourbon barrels mature across a cruise fleet, their flavors shaped by the maritime conditions of Holland America's carefully crafted itinerariesSEATTLE, March 27, 2026 /CNW/ -- To celebrate International Whiskey Day today, Holland America Line and Jefferson's Bourbon are announcing a partnership for a first-of-its-kind collaboration in which Jefferson's Ocean Bourbon is aged at sea across the cruise line's fleet. This marks the distillery's maiden voyage partnering with a cruise line for its Ocean Aged at Sea® Bourbon series. The program expands Holland America Line's award-winning Single Barrel Program and marks a new milestone in its America's 250th celebration, which h

    3/27/26 7:00:00 AM ET
    $CCL
    $CUK
    Marine Transportation
    Consumer Discretionary

    $BHIL
    $BRG
    $CANF
    $CCL
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 3 filed by Can-Fite Biopharma Ltd

    3 - Can-Fite BioPharma Ltd. (0001536196) (Issuer)

    3/18/26 8:14:39 AM ET
    $CANF
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form 3 filed by Can-Fite Biopharma Ltd

    3 - Can-Fite BioPharma Ltd. (0001536196) (Issuer)

    3/18/26 8:13:24 AM ET
    $CANF
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form 3 filed by Can-Fite Biopharma Ltd

    3 - Can-Fite BioPharma Ltd. (0001536196) (Issuer)

    3/18/26 8:09:46 AM ET
    $CANF
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $BHIL
    $BRG
    $CANF
    $CCL
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Carnival upgraded by Morgan Stanley with a new price target

    Morgan Stanley upgraded Carnival from Equal-Weight to Overweight and set a new price target of $31.00

    3/19/26 8:22:53 AM ET
    $CCL
    Marine Transportation
    Consumer Discretionary

    Summit Therapeutics downgraded by Jefferies with a new price target

    Jefferies downgraded Summit Therapeutics from Buy to Hold and set a new price target of $15.00

    3/16/26 8:36:55 AM ET
    $SMMT
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Oppenheimer initiated coverage on Spruce Biosciences with a new price target

    Oppenheimer initiated coverage of Spruce Biosciences with a rating of Outperform and set a new price target of $283.00

    12/23/25 8:47:57 AM ET
    $SPRB
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $BHIL
    $BRG
    $CANF
    $CCL
    SEC Filings

    View All

    Society Pass Incorporated filed SEC Form 8-K: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing

    8-K - SOCIETY PASS INCORPORATED. (0001817511) (Filer)

    3/27/26 4:20:26 PM ET
    $SOPA
    Real Estate

    SEC Form S-8 filed by Local Bounti Corporation

    S-8 - Local Bounti Corporation/DE (0001840780) (Filer)

    3/27/26 4:03:29 PM ET
    $LOCL
    Farming/Seeds/Milling
    Consumer Staples

    SEC Form 10-K filed by Local Bounti Corporation

    10-K - Local Bounti Corporation/DE (0001840780) (Filer)

    3/27/26 4:02:16 PM ET
    $LOCL
    Farming/Seeds/Milling
    Consumer Staples

    $BHIL
    $BRG
    $CANF
    $CCL
    Leadership Updates

    Live Leadership Updates

    View All

    DISTINGUISHED GUEST SPEAKERS TO JOIN SEABOURN CONVERSATIONS ON 2027 WORLD CRUISE

    World-Class Experts, Explorers, and Cultural Figures to Enrich 145-Day Global Journey Aboard Seabourn Quest SEATTLE, March 19, 2026 /PRNewswire/ -- Seabourn, the leader in luxury cruises and expedition travel, has announced a distinguished lineup of speakers joining its acclaimed Seabourn Conversations program for the 2027 World Cruise aboard Seabourn Quest. The 145–day voyage will feature a curated roster of storytellers, adventurers, and thought leaders, who will share insights and perspectives designed to enrich the journey and deepen guests' connection to the destinations they explore.

    3/19/26 2:47:00 PM ET
    $CCL
    $CUK
    Marine Transportation
    Consumer Discretionary

    Princess Cruises Announces 2028 World Cruise: 115-Day Global Voyage Visiting 49 Destinations Onboard Coral Princess

    See the World, Unpack Once: 2028 World Cruise Features Maiden Call to Mossel Bay, South Africa and Expanded More Ashore ExperiencesFORT LAUDERDALE, Fla., March 10, 2026 /PRNewswire/ -- Princess Cruises announces its spectacular 2028 World Cruise onboard Coral Princess, a 115-day, globe-spanning journey to 49 destinations across 24 countries and five continents - featuring 39 UNESCO World Heritage Sites, more overnight and late-night stays, and a maiden call to Mossel Bay, South Africa, on sale today. Departing January 3, 2028, roundtrip from Fort Lauderdale, or Los Angeles, the

    3/10/26 2:30:00 PM ET
    $CCL
    $CUK
    Marine Transportation
    Consumer Discretionary

    Spruce Biosciences Reports Full Year 2025 Financial Results and Provides Corporate Updates

    Following Positive Type B Meetings with the FDA, BLA Submission for TA-ERT for the Treatment of Sanfilippo Syndrome Type B (MPS IIIB) on Track for the Fourth Quarter of 2026 Appoints Dale Hooks as Chief Commercial Officer, Strengthening the Company's Commercial Capabilities in Preparation for a Potential Launch of TA-ERT Secured up to $50 Million in Growth Capital from Avenue Capital Group Spruce Biosciences, Inc. (NASDAQ:SPRB), a late-stage biopharmaceutical company focused on developing and commercializing novel therapies for neurological disorders with significant unmet medical need, today reported financial results for the year ended December 31, 2025 and provided corporate update

    3/9/26 7:05:00 AM ET
    $SPRB
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $BHIL
    $BRG
    $CANF
    $CCL
    Financials

    Live finance-specific insights

    View All

    CARNIVAL CORPORATION & PLC ACHIEVES RECORD FIRST QUARTER OPERATING RESULTS AND RECORD BOOKINGS

    Introduces PROPEL, ambitious targets designed to reflect continued earnings growth momentum through 2029Announces initial $2.5 billion share buyback programMIAMI, March 27, 2026 /PRNewswire/ -- Carnival Corporation & plc ((NYSE/LSE: CCL, NYSE:CUK) announced financial results for the first quarter 2026 and provided an updated outlook. Diluted EPS of $0.19 and adjusted EPS1 of $0.20, up 50 percent compared to the prior year.Record revenues2 of $6.2 billion, gross margin yields up nearly 10 percent and record net yields1,2 (in constant currency), outperforming guidance on strong close-in demand.Bookings for 2026 up double digits, further strengthening the company's record booked position at his

    3/27/26 9:15:00 AM ET
    $CCL
    $CUK
    Marine Transportation
    Consumer Discretionary

    Local Bounti Announces Fourth Quarter and Full Year 2025 Financial Results

    Delivered 27% Annual Revenue Growth and Improved Net Loss and Adjusted EBITDA While Advancing Strategic Retail Partnership DiscussionsDuring the First Quarter 2026, Secured New Retail Accounts to Expand Distribution and Improve Channel MixExisting Strategic Investor Closed on Additional $15 Million in Growth CapitalIssued U.S. Patent for Computer Vision and AI-Driven Growing OptimizationHAMILTON, Mont., March 25, 2026 /PRNewswire/ -- Local Bounti Corporation (NYSE:LOCL) ("Local Bounti" or the "Company"), a breakthrough U.S. indoor agriculture company currently servicing approximately 13,000 retail doors, today announced its financial results for the three and twelve months ended December 31,

    3/25/26 7:15:00 AM ET
    $LOCL
    Farming/Seeds/Milling
    Consumer Staples

    Local Bounti to Release Full Year 2025 Financial Results on Wednesday, March 25, 2026

    HAMILTON, Mont., March 23, 2026 /PRNewswire/ -- Local Bounti Corporation (NYSE:LOCL) ("Local Bounti" or the "Company"), a breakthrough U.S. indoor agriculture company, today announced it will release its financial results for the fiscal full year ended December 31, 2025, before the market opens on Wednesday, March 25, 2026. Conference CallThe Company will host a conference call with members of the Local Bounti executive management team to discuss financial results and other business updates. The conference call is scheduled to begin at 8:00 a.m. ET on Wednesday, March 25, 2026.

    3/23/26 8:00:00 AM ET
    $LOCL
    Farming/Seeds/Milling
    Consumer Staples

    $BHIL
    $BRG
    $CANF
    $CCL
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by Spruce Biosciences Inc.

    SC 13G/A - SPRUCE BIOSCIENCES, INC. (0001683553) (Subject)

    11/14/24 5:45:17 PM ET
    $SPRB
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Amendment: SEC Form SC 13G/A filed by Can-Fite Biopharma Ltd Sponsored ADR (Israel)

    SC 13G/A - Can-Fite BioPharma Ltd. (0001536196) (Subject)

    11/14/24 4:48:49 PM ET
    $CANF
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Amendment: SEC Form SC 13G/A filed by Spruce Biosciences Inc.

    SC 13G/A - SPRUCE BIOSCIENCES, INC. (0001683553) (Subject)

    11/14/24 4:39:47 PM ET
    $SPRB
    Biotechnology: Pharmaceutical Preparations
    Health Care